Physician profile
Roy Roso
NPI 1144328857
$1,003.60
in general payments reported to CMS, 2019-2025
22 companies · $33.13 in 2025
The $33.13 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $256 · 2023: $145 · 2024: $457 · 2025: $33.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509 · Travel and Lodging: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.28 |
| Travel and Lodging | $125.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $247.10 | 2024 | Senza |
| Novo Nordisk INC | $220.22 | 2021-2023 | Wegovy, Rybelsus |
| Abbvie INC. | $71.17 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.25 | 2021-2023 | Xifaxan |
| Xeris Pharmaceuticals, INC. | $46.95 | 2023-2024 | Keveyis, Gvoke Hypopen |
| Lilly USA, LLC | $39.33 | 2024 | Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $28.14 | 2021-2022 | |
| Amgen INC. | $27.44 | 2022 | |
| Currax Pharmaceuticals LLC | $27.13 | 2022-2023 | Onzetra Xsail, Nexletol, Nexlizet |
| Depuy Synthes Sales INC. | $24.40 | 2024 | |
| Merck Sharp & Dohme LLC | $20.73 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Alexion Pharmaceuticals, INC. | $20.11 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.00 | 2024 | Airsupra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $19.64 | 2022 | |
| Convatec INC. | $17.14 | 2025 | Aquacel Ag Surgical |
| Exact Sciences Corporation | $16.99 | 2023 | Cologuard Collection Kit |
| Qiagen, LLC | $16.85 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $15.99 | 2025 | |
| Glaxosmithkline, LLC. | $15.67 | 2024 | Trelegy Ellipta, Arexvy |
| Biogen, INC. | $14.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Roso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.